Saliva test for monitoring blood sugar in diabetes
Part of Hormones & metabolism clinical trials.
This study evaluates a new saliva test for measuring 1,5-anhydroglucitol, a marker that may help monitor blood sugar control in people with diabetes. Participants will provide saliva samples to see if this non-invasive test can accurately reflect glucose levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You either do not have diabetes or have type 2 diabetes.
- You have not taken systemic glucocorticoids (like prednisone) in the last 6 weeks.
- You do not currently have an acute infection.
- You do not have severe oral conditions that could affect saliva collection.
- You do not have severe liver or kidney disease.
- You do not have a history of alcohol abuse or psychiatric disorders (including depression).
- You are not currently taking SGLT2 inhibitors (e.g., canagliflozin, dapagliflozin, empagliflozin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a simple saliva test can find high cortisol levels in people with hard-to-control type 2 diabetes. It aims to help doctors identify if cortisol problems are making diabetes worse.
This trial is checking how well blood sugar is controlled in adults recently diagnosed with type 2 diabetes (within the last 3 months). It aims to see if current treatments or lifestyle changes are working and may help guide future care.
This study checks whether certain substances in saliva can help detect gum disease in people with type 2 diabetes. It compares the levels of these substances in people with diabetes and gum disease, people with gum disease only, people with diabetes only, and healthy volunteers.
This study measures “circulating biomarkers” (blood-based signals) in people with type 1 or type 2 diabetes, and in some people without diabetes who test positive for certain diabetes antibodies. The goal is to understand what these blood signals can tell us about diabetes development and progression.
This trial studies how anhydroglucitol behaves in children with type 1 diabetes who use insulin pump therapy and glucose monitoring. Your team will compare measurements over about a year to see if this marker could be useful for tracking diabetes control.
This study watches blood sugar changes over time in people who do not yet have diabetes but have test results that suggest risk for type 1 diabetes. The goal is to see whether “blood sugar variability” can predict when high or low blood sugar may happen, even before symptoms.
Hear when a new Type 2 Diabetes (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.